NCT00957684View on ClinicalTrials.gov

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

February 28, 2007

Conditions
Refractory Partial Epilepsy
Interventions
DRUG

eslicarbazepine acetate

once-daily oral tablet

DRUG

placebo

once daily placebo comparator

Trial Locations (1)

4745-457

Bial - Portela & Cª, S.A., São Mamede do Coronado

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT00957684 - Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures | Biotech Hunter | Biotech Hunter